TGTX

TG-1801

CD47/CD19

Phase 1

Exp Date

TBD

Amp Volatility Score

Catalyst Info & Data Links

Catalyst Events

  • Phase 1 Data


Clinical Trial

  • NCT03804996: Study of TG-1801 in Subjects With B-Cell Lymphoma


Prior Data Links


HC updated 5/21/20

Prior Data (click to view full image)

Chart

Trial Design / Revenue (click to view full image)

Chart

Recent Posts

See What The Community Is Saying - Click To See Full Post

#TGTX - Acceptance of #NDA for...

#TGTX announced that the FDA has accepted their NDA #umbralisib. See more at our AmpCard for more details. #TGTX, #Umbralisib, #MZL, #FL, #lymphoma...

Will TGTX's Unity CLL PFS Read...

QUESTION: Is TGTX going to report positive results that increases their stock price, when they report their upcoming Phase 3 Unity-CLL PFS readout*? On Sept. 25, 2018, TGTX took a big hit to its cred...

Educational video - Near-term ...

Check out my recent video in our educational forum, which discusses the unfortunate reality of small and mid-cap biopharma investing: near-term dilution. Case studies are provided for CARA and TGTX, ...

*Disclaimer: Information provided on ampbiotechresearch.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon